I am happy to announce that a manuscript detailing a AEX and VF spiking study performed with MedImmune (AstraZeneca) and Texcell has been published in Biotechnology Progress. Click here for a good read!
{iframe}https://www.linkedin.com/posts/david-cetlin-a7955764_using-a-noninfectious-mvm-surrogate-for-assessing-activity-6590218732163919872-OlRj/{/iframe}